Press Releases about Inmune Bio Inc
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
September 30, 2024
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Announces $13.0 Million Registered Direct Offering
September 13, 2024
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
September 03, 2024
From INmune Bio, Inc.
Via GlobeNewswire
From INmune Bio, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|